HeartCore Reports Financial Results for Second Quarter and Six Months Ended June 30, 2025

Rhea-AI Summary

HeartCore Enterprises (Nasdaq: HTCR), a Tokyo-based enterprise software and consulting company, reported its Q2 2025 financial results, marking a return to profitability. The company achieved Q2 revenues of $4.7 million, up 16.7% year-over-year, driven by increased on-premise software sales and SaaS revenue.

Key Q2 metrics include a 175.2% increase in gross profit to $2.2 million and a net income of $1.1 million, compared to a $2.2 million loss in the previous year. The company's cash position strengthened to $2.3 million as of June 30, 2025. HeartCore secured its 15th and 16th Go IPO contracts and established strategic partnerships with Silver Egg Technology and NEC Solutions Innovators to enhance its CMS platform.

Positive

• Return to profitability with Q2 net income of $1.1 million, compared to $2.2 million loss year-over-year
• Q2 revenue increased 16.7% to $4.7 million year-over-year
• Gross profit surged 175.2% to $2.2 million in Q2
• Operating expenses decreased to $2.1 million from $2.3 million year-over-year
• Achieved compliance with Nasdaq's $2.5M minimum shareholders' equity requirement
• Secured 15th and 16th Go IPO contracts

Negative

• Six-month revenue declined to $8.3 million from $9.1 million year-over-year
• Net loss of $2.1 million for the six-month period
• Decreased customized software development revenue due to intense U.S. market competition
• Reduced Go IPO consulting services revenue due to fewer ongoing IPO projects

Insights

Financial Analyst

HeartCore returns to profitability in Q2 with revenue growth and improved margins, though H1 shows mixed results amid business strategy shifts.

HeartCore's Q2 2025 results show a company successfully executing its strategic pivot toward higher-margin business segments. Revenue increased 16.7% year-over-year to $4.7 million, with particularly strong performance in on-premise software sales and SaaS offerings. The standout metric is gross profit, which surged 175.2% to $2.2 million, demonstrating substantially improved margins.

The company achieved net income of $1.1 million in Q2, a dramatic improvement from the $2.2 million loss in the same period last year. This return to profitability occurred despite having no Go IPO client listings during the quarter, highlighting the strength of the core software business. Management's strategic shift toward higher-margin software products appears to be paying off, with reduced operating expenses contributing to the bottom-line improvement.

For the six-month period, results were more mixed. Revenue declined to $8.3 million from $9.1 million, primarily due to decreased customized software development services amid heightened U.S. competition and fewer Go IPO consulting projects. However, gross profit still increased 16.9% to $3.3 million, and net loss improved to $2.1 million from $3.7 million.

The balance sheet shows modest improvement with cash increasing to $2.3 million from $2.1 million at year-end 2024. Importantly, shareholders' equity of $3.5 million exceeds Nasdaq's $2.5 million requirement, removing a potential listing concern. With two new Go IPO contracts signed and an existing client expected to list on Nasdaq soon, HeartCore appears positioned for continued financial improvement in Q3 2025.

NEW YORK and TOKYO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading enterprise software and consulting services company based in Tokyo, reported financial results for the second quarter and six months ended June 30, 2025.

Second Quarter 2025 and Recent Operational & Financial Highlights

• As of June 30, 2025, HeartCore’s total shareholders’ equity totaled $3.5 million. The Company believes that it is now in compliance with the $2.5 million minimum stockholders’ equity requirement set forth in Nasdaq Listing Rule 5550(b) for continued listing on the Nasdaq Capital Market.
• Partnered with Silver Egg Technology CO., Ltd. to integrate new recommendation engine into its CMS platform.
• Signed 15^th and 16^th Go IPO Contract.
• Announced strategic partnership with NEC Solutions Innovators, Ltd. to enhance CMS implementation process.

Management Commentary
“I am pleased to report a strong second quarter, marked by our return to profitability,” said HeartCore CEO Sumitaka Kanno. “These results reflect the resilience of our software business, which was bolstered by a significant deal with a major infrastructure company that was closed during the quarter. Our second quarter results were particularly encouraging, especially during a period without any Go IPO client listings. We signed our 15^th and 16^th Go IPO contract wins late in the second quarter and early in the third quarter, but more notably, we expect one of our existing Go IPO clients to successfully list on the Nasdaq Stock Market in the near-term. This is expected to further strengthen our results in the third quarter. In the broader IPO market, there were several other APAC-based companies outside of our pipeline that successfully listed in 2025, which we view as a positive indicator for our Go IPO business. Looking ahead, we are excited to host our Go IPO Korea event next month, which we hope will mark the beginning of a stronger presence in the Korean market. With encouraging signs from the general IPO landscape, we remain focused on expanding our reach to APAC companies seeking to list on U.S. exchanges, while continuing to guide our existing clients throughout the listing process and ultimately, across the finish line as a publicly traded company.”

Second Quarter 2025 Financial Results
Revenues increased by 16.7% to $4.7 million, compared to $4.1 million in the same period last year. The increase was primarily due to (i) the increased sale of on-premise software mainly from multiple large orders of CMS licenses in the second quarter of 2025, compared to the same period last year, (ii) increased software-as-a-service (“SaaS”) revenue due to the Company putting more efforts into expanding and promoting its traditional SaaS business in Japan, and (iii) obtaining more orders, partially offset by (iv) a decrease in customized software development and services revenue in connection with the intense competition of the software market in the U.S., and a decrease in software development and other services, mainly as the Company shifted its business strategies to focus more on development and expansion its on-premise software revenue and SaaS revenue.

Gross profit increased 175.2% to $2.2 million, compared to $0.8 million in the same period last year. The increase was primarily due to (i) an increase in gross profit from sales of on-premise software as the sale increased dramatically while there was not much change in the corresponding costs as the product was developed independently and fixed costs which were not proportional to sales, (ii) an increase in gross profit from customized software development and services as Sigmaways reduced outsourcing costs by ending cooperation with costly vendors, resulting in costs that decreased more dramatically than revenue did, and (iii) an increase in gross profit from the Company’s IPO consulting services.
  
Operating expenses decreased to $2.1 million, compared to $2.3 million in the same period last year. The decrease was primarily due to a decrease in general and administrative expenses.

Net income was $1.1 million, compared to a net loss of $2.2 million in the same period last year, as a result of the aforementioned increases in revenue and gross profit.   

Adjusted EBITDA was $0.1 million for the second quarter of 2025, compared to $(1.2) million in the same period last year.

As of June 30, 2025, the Company had cash and cash equivalents of $2.3 million, compared to $2.1 million on December 31, 2024.

Six Months Ended June 30, 2025 Financial Results
Revenues were $8.3 million, compared to $9.1 million in the same period last year. The decrease was primarily due to (i) a decrease in customized software development and services revenue in connection with a slowdown in Sigmaways revenue, driven by intensified competition in the U.S. software market, (ii) decreased Go IPO consulting services revenue mainly due to fewer ongoing IPO consulting projects, (iii) decreased software development and other services revenue mainly as the Company shifted its business strategies to focus more on development and expansion of its on-premise software and SaaS revenue in the second quarter of 2025, resulting in fewer resources and efforts dedicated to software development and other services, partially offset by (iv) an increase in on-premise software revenue due to the Company obtaining several large CMS license orders in the current period.

Gross profit increased 16.9% to $3.3 million, compared to $2.8 million in the same period last year. The increase was primarily due to (i) an increase in gross profit from the sale of on-premise software, as sales rose significantly while related costs remained largely unchanged since the product was independently developed with fixed costs not proportional to sales, and (ii) increased gross profit from customized software development and services, as Sigmaways reduced outsourcing costs by ending cooperation with costly vendors in the current period.

Operating expenses decreased to $4.4 million, compared to $5.0 million in the same period last year. The improvement was primarily due to a decrease in general and administrative expenses.

Net loss improved to $2.1 million, compared to a loss of $3.7 million in the same period last year, as a result of the aforementioned increase in gross profit during the period and increase in revenue in the second quarter.

Adjusted EBITDA was $(1.1) million for the six months ended June 30, 2025, compared to $(1.6) million in the same period last year.

About HeartCore Enterprises, Inc.
Headquartered in Tokyo, Japan, HeartCore Enterprises is a leading enterprise software and consulting services company. HeartCore offers Software as a Service (SaaS) solutions to enterprise customers in Japan and worldwide. The Company also provides data analytics services that allow enterprise businesses to create tailored web experiences for their clients through best-in-class design. HeartCore’s customer experience management platform (CXM Platform) includes marketing, sales, service and content management systems, as well as other tools and integrations, which enable companies to enhance the customer experience and drive engagement. HeartCore also operates a digital transformation business that provides customers with robotics process automation, process mining and task mining to accelerate the digital transformation of enterprises. HeartCore’s GO IPO^SM consulting services helps Japanese-based companies go public in the U.S. Additional information about the Company’s products and services is available at and https://heartcore-enterprises.com/.

Non-GAAP Financial Measures Disclaimer
This document includes references to adjusted EBITDA, which is a non-GAAP financial measure. For the purposes of this presentation, adjusted EBITDA is calculated by adjusting net loss to exclude depreciation and amortization, changes in fair value of investments in marketable securities, changes in fair value of investment in warrants, interest income, and interest expenses.

This measure is presented as supplemental information and is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with accounting principles generally accepted in the U.S. (“GAAP”).

Management believes that adjusted EBITDA provides useful information to investors by highlighting the Company’s core operational performance, excluding non-cash and non-recurring items. However, non-GAAP financial measures have limitations and should not be considered in isolation or as a substitute for financial results prepared in accordance with GAAP.

	For the three months ended June 30,
Item	2025	2024
Net loss	$1.1 million	-$2.2 million
(+) Depreciation and amortization expense	$0.0 million	$0.2 million
(+) Changes in fair value of investments in marketable securities	-$0.9 million	$0.2 million
(+) Changes in fair value of investment in warrants	-$0.1 million	$0.6 million
(-) Interest income	-$0.0 million	-$0.0 million
(+) Interest expenses	$0.0 million	$0.0 million
Adjusted EBITDA	$0.1 million	-$1.2 million

	For the six months ended June 30,
Item	2025	2024
Net loss	-$2.1 million	-$3.7 million
(+) Depreciation and amortization expense	$0.0 million	$0.4 million
(+) Changes in fair value of investments in marketable securities	$0.9 million	$0.4 million
(+) Changes in fair value of investment in warrants	-$0.1 million	$1.2 million
(-) Interest income	-$0.0 million	-$0.0 million
(+) Interest expenses	$0.1 million	$0.1 million
Adjusted EBITDA	-$1.1 million	-$1.6 million

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, or the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “believed,” “intend,” “expect,” “anticipate,” “plan,” “potential,” “continue,” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks, and uncertainties are discussed in HeartCore’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond HeartCore’s control which could, and likely will materially affect actual results, and levels of activity, performance, or achievements. Any forward-looking statement reflects HeartCore’s current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. HeartCore assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.

HeartCore Investor Relations Contact:
Gateway Group, Inc.
Matt Glover and John Yi
HTCR@gateway-grp.com
(949) 574-3860

HeartCore Enterprises, Inc.
Consolidated Balance Sheets
		June 30,			December 31,
		2025			2024
		(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	2,347,622		$	2,121,089
Accounts receivable		3,000,337			1,950,050
Investments in marketable securities		2,495,016			4,495,703
Prepaid expenses		503,171			458,839
Current portion of long-term note receivable		100,000			100,000
Due from related party		44,148			40,139
Deferred offering costs		250,000			-
Other current assets		186,944			251,545
Total current assets		8,927,238			9,417,365
Non-current assets:
Accounts receivable, non-current		1,058,539			752,930
Property and equipment, net		442,475			584,854
Operating lease right-of-use assets		1,853,466			1,936,097
Long-term investment in warrants		650,446			577,786
Long-term note receivable		100,000			100,000
Deferred tax assets		138,263			152,300
Security deposits		225,649			307,996
Long-term loan receivable from related party		114,230			123,928
Other non-current assets		15,014			11,778
Total non-current assets		4,598,082			4,547,669
Total assets	$	13,525,320		$	13,965,034
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable and accrued expenses	$	1,758,084		$	2,039,323
Accounts payable and accrued expenses - related party		22,924			47,199
Accrued payroll and other employee costs		752,787			675,502
Due to related parties		590			932
Short-term debt - related party		75,000			75,000
Current portion of long-term debts		382,494			401,255
Insurance premium financing		90,869			16,626
Factoring liability		226,212			172,394
Operating lease liabilities, current		290,886			371,951
Finance lease liabilities, current		17,666			15,956
Income tax payables		716,263			822,014
Deferred revenue		1,702,068			1,876,490
Derivative liability		236,141			-
Other current liabilities		821,858			907,080
Total current liabilities		7,093,842			7,421,722
Non-current liabilities:
Long-term debts		1,097,263			1,238,813
Operating lease liabilities, non-current		1,613,378			1,614,996
Finance lease liabilities, non-current		39,085			43,593
Asset retirement obligations		122,735			183,895
Total non-current liabilities		2,872,461			3,081,297
Total liabilities		9,966,303			10,503,019
Shareholders' equity:
Preferred shares, $0.0001 par value, 20,000,000 shares authorized; Series A convertible preferred shares, 2,000 and no shares designated, issued and outstanding as of June 30, 2025 and December 31, 2024, respectively; aggregate liquidation preference of $2,200,611 and nil as of June 30, 2025 and December 31, 2024, respectively		-			-
Common shares, $0.0001 par value, 200,000,000 shares authorized, 23,310,770 and 21,937,987 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively		2,331			2,193
Subscription receivable		-			(103,942	)
Additional paid-in capital		22,676,912			20,656,153
Accumulated deficit		(18,231,933	)		(16,244,843	)
Accumulated other comprehensive income		393,124			343,936
Total HeartCore Enterprises, Inc. shareholders' equity		4,840,434			4,653,497
Non-controlling interests		(1,281,417	)		(1,191,482	)
Total shareholders' equity		3,559,017			3,462,015
Total liabilities and shareholders' equity	$	13,525,320		$	13,965,034

HeartCore Enterprises, Inc.
Unaudited Consolidated Statements of Operations and Comprehensive Income (Loss)
		For the six months ended June 30,
		2025				2024
Revenues	$	8,331,272			$	9,113,120
Cost of revenues		5,013,393				6,275,050
Gross profit		3,317,879				2,838,070
Operating expenses:
Selling expenses		676,782				399,115
General and administrative expenses		3,492,415				4,428,712
Research and development expenses		285,374				200,402
Total operating expenses		4,454,571				5,028,229
Income (loss) from operations		(1,136,692	)			(2,190,159	)
Other income (expenses):
Changes in fair value of investments in marketable securities		(928,955	)			(430,331	)
Changes in fair value of investment in warrants		72,660				(1,237,707	)
Interest income		4,861				4,624
Interest expenses		(61,798	)			(73,701	)
Other income		56,920				134,874
Other expenses		(29,797	)			(49,050	)
Total other income (expenses)		(886,109	)			(1,651,291	)
Income (loss) before income tax expense (benefit)		(2,022,801	)			(3,841,450	)
Income tax expense (benefit)		53,074				(152,330	)
Net income (loss)		(2,075,875	)			(3,689,120	)
Less: net loss attributable to non-controlling interests		(88,785	)			(404,670	)
Net income (loss) attributable to HeartCore Enterprises, Inc.		(1,987,090	)			(3,284,450	)
Dividends accrued on Series A convertible preferred shares		(611	)			-
Net income (loss) attributable to HeartCore Enterprises, Inc. common shareholders	$	(1,987,701	)		$	(3,284,450	)
Other comprehensive income (loss):
Foreign currency translation adjustment		48,038				(13,825	)
Total comprehensive income (loss)		(2,027,837	)			(3,702,945	)
Less: comprehensive loss attributable to non-controlling interests		(89,935	)			(412,471	)
Comprehensive income (loss) attributable to HeartCore Enterprises, Inc.	$	(1,937,902	)		$	(3,290,474	)
Net income (loss) per common share attributable to HeartCore Enterprises, Inc.
Basic	$	(0.09	)		$	(0.16	)
Diluted	$	(0.09	)		$	(0.16	)
Weighted average common shares outstanding
Basic		22,072,324				20,859,429
Diluted		22,072,324				20,859,429

HeartCore Enterprises, Inc.
Unaudited Consolidated Statements of Cash Flows
		For the six months ended June 30,
		2025			2024
Cash flows from operating activities:
Net loss	$	(2,075,875	)	$	(3,689,120	)
Adjustments to reconcile net loss to net cash flows
used in operating activities:
Depreciation and amortization expenses		42,437			374,946
Loss on disposal of property and equipment		117,305			1,894
Amortization of debt issuance costs		2,194			2,296
Non-cash lease expense		163,354			182,546
Gain on termination of lease		(9,059	)		(469	)
Deferred income taxes		28,008			(153,531	)
Stock-based compensation		60,204			147,754
Changes in fair value of investments in marketable securities		928,955			430,331
Changes in fair value of investment in warrants		(72,660	)		1,237,707
Gain on settlement of asset retirement obligations		(45,873	)		-
Changes in assets and liabilities:
Accounts receivable		(1,145,166	)		(823,402	)
Prepaid expenses		126,001			158,110
Other assets		182,063			(7,526	)
Accounts payable and accrued expenses		(320,566	)		272,375
Accounts payable and accrued expenses - related party		(23,386	)		21,956
Accrued payroll and other employee costs		31,589			(278,361	)
Due to related parties		(370	)		(1,246	)
Operating lease liabilities		(159,030	)		(183,047	)
Income tax payables		(108,943	)		(152,697	)
Deferred revenue		(282,704	)		165,073
Other liabilities		(113,370	)		558,667
Net cash flows used in operating activities		(2,674,892	)		(1,735,744	)
Cash flows from investing activities:
Purchases of property and equipment		(1,235	)		(4,134	)
Prepayment for property and equipment		-			(35,209	)
Purchase of investment in SAFE		-			(75,000	)
Net proceeds from sale of warrants		-			5,640,000
Proceeds from sale of marketable securities		1,071,732			-
Repayment of loan provided to related party		21,139			21,166
Net cash flows provided by investing activities		1,091,636			5,546,823
Cash flows from financing activities:
Payments for finance leases		(8,375	)		(8,526	)
Proceeds from short-term debt		134,689			68,138
Repayment of short-term and long-term debts		(395,495	)		(281,451	)
Repayment of insurance premium financing		(65,257	)		(60,201	)
Net proceeds from factoring arrangement		53,818			-
Net repayment of factoring arrangement		-			(242,008	)
Capital contribution from non-controlling shareholder		-			67,195
Distribution of dividends		-			(417,283	)
Proceeds from issuance of common shares		30,445			-
Proceeds from collection of subscription receivable		103,942			-
Proceeds from exercise of stock options		117,000			-
Proceeds from issuance of Series A convertible preferred shares and common shares related to securities purchase agreement, net of share issuance costs		1,800,000			-
Net cash flows provided by (used in) financing activities		1,770,767			(874,136	)
Effect of exchange rate changes		39,022			(143,073	)
Net change in cash and cash equivalents		226,533			2,793,870
Cash and cash equivalents - beginning of the period		2,121,089			1,012,479
Cash and cash equivalents - end of the period	$	2,347,622		$	3,806,349
		-
Supplemental cash flow disclosures:
Interest paid	$	63,320		$	74,063
Income taxes paid	$	131,118		$	117,524
Non-cash investing and financing transactions:
Operating lease right-of-use assets obtained in exchange for operating lease liabilities	$	23,495		$	125,735
Insurance premium financing	$	139,500		$	172,689
Warrants converted to marketable securities	$	-		$	223,481
Issuance of common shares related to equity purchase agreement	$	250,000		$	-
Dividends accrued on Series A convertible preferred shares	$	611		$	-

FAQ

What were HeartCore's (HTCR) Q2 2025 earnings results?

HeartCore reported Q2 2025 revenue of $4.7 million (up 16.7% YoY), gross profit of $2.2 million (up 175.2%), and net income of $1.1 million, compared to a $2.2 million loss in Q2 2024.

How much cash does HeartCore (HTCR) have as of Q2 2025?

HeartCore had $2.3 million in cash and cash equivalents as of June 30, 2025, compared to $2.1 million on December 31, 2024.

Is HeartCore (HTCR) compliant with Nasdaq listing requirements?

Yes, HeartCore reported total shareholders' equity of $3.5 million, which exceeds Nasdaq's minimum requirement of $2.5 million for continued listing.

What is driving HeartCore's (HTCR) revenue growth in Q2 2025?

Growth was primarily driven by increased on-premise software sales from large CMS license orders, higher SaaS revenue from expanded Japanese operations, and increased order volume.

How many Go IPO contracts does HeartCore (HTCR) currently have?

HeartCore secured its 15th and 16th Go IPO contracts in late Q2 and early Q3 2025, with one existing client expected to list on Nasdaq in the near term.